ctDNA Could Aid in Treatment Escalation and De-escalation Decisions in Kidney Cancer
2 years ago
57
Alan Tan, MD, discusses how utilizing circulating tumor DNA may provide valuable insight into when to escalate vs de-escalate treatment for patients with renal cell carcinoma.